Article

marketwatch.com on 2019-06-17 19:33

Adaptive Biotechnologies sets terms for IPO, to raise up to $212.5 million

Adaptive Biotechnologies Corp. set terms for its initial public offering Monday, in which the developer of immune-system derived disease treatments is...

Related news